Results 31 to 40 of about 2,174 (166)

PML bodies in reactive sensory ganglion neurons of the Guillain–Barré syndrome

open access: yesNeurobiology of Disease, 2004
Acute inflammatory demyelinating polyneuropathy (AIDP) is a type of Guillain–Barré syndrome (GBS) characterized by primary nerve demyelination sometimes with secondary axonal degeneration.
Nuria T Villagrá   +6 more
doaj   +1 more source

The lack of H-reflex as an additional neurophysiological sign of development of acute inflammatory demyelinating polyneuropathy in children

open access: yesАнналы клинической и экспериментальной неврологии, 2017
Early diagnosis of acute inflammatory demyelinating polyneuropathy (AIDP) is of fundamental importance for the timely prescription of therapy. The conventionally used techniques of electrophysiological diagnosis are not sensitive enough at early stages ...
Vladislav B. Voitenkov   +4 more
doaj   +1 more source

Association Between A-Waves and Outcome in Pediatric Guillain-Barré Syndrome

open access: yesFrontiers in Neurology, 2022
IntroductionTo examine the importance of abundant A-waves in electrophysiological classification and prognosis of pediatric Guillain-Barré Syndrome (GBS).MethodsA single-center and retrospective study enrolling 65 children-patients, aged 16 years and ...
Mei Jin   +4 more
doaj   +1 more source

Guillain-Barre syndrome: recovery patterns in demyelinating and axonal forms

open access: yesАнналы клинической и экспериментальной неврологии, 2017
We carried out an examination of 74 patients who have had,from 3 months to 36 years ago, GuillainBarre syndrome (GBS)with severe impairmenet of motor functions. The average follow-up period was 2.3 years.
D. A. Grishinа   +2 more
doaj   +1 more source

Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial

open access: yesSleep Medicine: X
Objective/Background: Sleep problems challenge overall wellbeing. Magnesium has been implicated to benefit sleep, although the clinical evidences varied based on the magnesium source used.
Heather A. Hausenblas   +5 more
doaj   +1 more source

Outcome of Patients with Gullain Barre syndrome at Tertiary Care Hospital in Eastern Nepal

open access: yesJournal of Nobel Medical College, 2018
Background: Gullain Barre syndrome is the most common cause of acute flaccid paralysis. Early diagnosis and treatment improves survival in patients with Gullain Barre Syndrome.
Dilli Ram Kafle, Surendra Shah
doaj   +1 more source

Subtypes and Prognosis of Guillain-Barré Syndrome in Southwest China. [PDF]

open access: yesPLoS ONE, 2015
The proportion of different subtypes of Guillain-Barré syndrome (GBS) and their prognosis varied significantly among different regions. This study attempts to investigate the clinical subtypes and outcome of GBS in southwest China.
Gang Zhang   +5 more
doaj   +1 more source

AIDP BEFORE AND AFTER COVID-19 IN ALGERIA: SHORT COHORT STUDY

open access: yesEPRA International Journal of Multidisciplinary Research (IJMR), 2023
Acute inflammatory demyelinating polyradiculoneuropathy is an immune-mediated polyneuropathy (AIDP) that manifests in the form of an acute, ascending, areflexic, progressive and symmetrical paralysis. The primary infection usually from the respiratory or gastrointestinal tract and can be bacterial or viral, and during the pandemic SARS -COV2 and COVID ...
null T. Ait Mouheb   +2 more
openaire   +1 more source

Comparison of the effects of different doses of Glucocorticoids on distinct subtypes of Guillain-Barré syndrome in Southern China

open access: yesBMC Neurology, 2022
Background The effect of Glucocorticoids (GCs) on the treatment of Guillain-Barré syndrome (GBS) has been controversial. There is no information on whether specific subtypes of GBS respond differently to GCs.
Linzhuo Ma   +6 more
doaj   +1 more source

Diffusion MRI and α‐Synuclein Seed Amplification Status in Parkinson's Disease

open access: yesAnnals of Neurology, Volume 100, Issue 2, Page 295-304, August 2026.
Objective Positive α‐synuclein seed amplification assay (SAA) is a biomarker found in most people with Parkinson's disease (PD). We explored if free‐water (FW) imaging detects microstructural differences in the brains of patients with early PD with SAA+ or SAA– status.
Shannon Y. Chiu   +145 more
wiley   +1 more source

Home - About - Disclaimer - Privacy